Daljeet Singh Gambhir | |
|---|---|
| Born | Delhi, India |
| Occupation(s) | Interventional cardiologist Medical researcher Medical administrator |
| Known for | Multivessel angioplasty Medical research |
| Awards | Padma Shri DMA Life Time Achievement Award AACIO Distinguished Physician Award Government of Delhi State Award |
Daljeet Singh Gambhir is an Indian cardiologist, medical academic, researcher and inventor and the Group Director of Cardiology atKailash Group of Hospitals and Heart Institute, Noida.[1] He is the inventor ofInfinnium Paclitaxel-Eluting Stent, a reportedly cheaperdrug-eluting stent which he first presented at the EuroPCR meeting held in Paris in 2003.[2] A fellow of theNational Academy of Medical Sciences[3] and an honorary fellow of the Indian College of Cardiology, he is reported to have performed over 10,000 coronary interventions.[4] The Government of India awarded him the fourth highest civilian honour of thePadma Shri, in 2016, for his contributions to medicine.[5]
Daljeet Singh Gambhir graduated in medicine fromMaulana Azad Medical College and followed it up with a post graduate degree (MD) from the same institution after which he secured the degree of DM.[6] He started his career as an assistant professor at the department of cardiology of Govind Ballabh Pant Institute of Postgraduate Medical Education, New Delhi in 1985 where he became a professor in 1993, at the age of 44.[7] During his tenure, he is known to have established a radiation therapy department at the hospital for the treatment ofcoronary restenosis.[8] Later he moved to Kailash Group of Hospitals where he is the group director of cardiology and the chief executive officer of its heart institute.[9]
Gambhir, known to have specialized in non-surgical coronary interventional techniques, is reported to have performed over 10,000 interventional procedures.[4] He is known to have conducted researches and clinical trials on various interventional techniques and invented adrug-eluting stent, known asInfinnium Paclitaxel-Eluting Stent, which was presented at the ParisEuroPCR meeting of 2003 after conducting clinical trials on 80 patients.[2] The stent was reported to have been more cost effective than the ones available at the market during that time. He has published over 110 articles in peer-reviewed journals and has contributed chapters to many medical text books published by others.[6] He is one of the founding members of the Indian College of Cardiology and a former president of the institution (2007–08), where he is a life member.[10] He is the clinical advisor to MIV Therapeutics, a medical institution working on biocompatible coatings for passive and drug-eluting stents,[8] and a consultant editor of the Indian Heart Journal.[11] He is a former president of the Cardiological Society of India (2002–03), chaired its scientific committee in 2002 and is a member of its executive committee.[12]
TheNational Academy of Medical Sciences elected Gambhir as their fellow in 2004.[13] He has received the State Award from the Government of Delhi as well as the Lifetime Achievement Award of the Delhi Medical Association.[4] The Government of India included him in theRepublic Day honors list for the civilian award of thePadma Shri in 2016.[14][15] He is also recipient of theDistinguished Physician Award of the Association of American Cardiologists of Indian Origin[7] and an honorary fellow of Indian College of Cardiology (2005), Cardiological Society of India (2006) and College of Asian Pacific Society of Cardiology (2007) and theAmerican College of Cardiology.[9]
